Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Thyroid Associated Orbitopathy”

30 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 30 results

Post-approval studies (Phase 4)Not Yet RecruitingNCT03098225
What this trial is testing

A Trial to Evaluate the Efficacy of Orbital Radiotherapy in Graves' Orbitopathy

Who this might be right for
Thyroid Associated Ophthalmopathy
University of Pisa 120
Not applicableStudy completedNCT03535090
What this trial is testing

Coagulation After Intravenous Methylprednisolone Administration

Who this might be right for
Graves' DiseaseGraves OphthalmopathyBlood Coagulation+1 more
Piotr Miskiewicz 26
Not applicableStudy completedNCT07393230
What this trial is testing

Changes in Orbital Macrovascular and Intraocular Microvascular Blood Flow After Orbital Decompression Surgery in Patients With Thyroid Eye Disease

Who this might be right for
Thyroid Associated Orbitopathy
Marmara University Pendik Training and Research Hospital 15
Large-scale testing (Phase 3)Study completedNCT01297699
What this trial is testing

Tocilizumab Treatment in Graves´ Ophthalmopathy (Graves´ Orbitopathy or Thyroid Eye Disease)

Who this might be right for
Thyroid Associated OphthalmopathiesGraves´ OphthalmopathyThyroid Eye Disease
Hospital Clinico Universitario de Santiago 32
Large-scale testing (Phase 3)Looking for participantsNCT06112340
What this trial is testing

Extension Study of Two Doses of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED)

Who this might be right for
Thyroid Eye DiseaseGraves OrbitopathyEndocrine System Diseases+9 more
Sling Therapeutics, Inc. 75
Early research (Phase 1)Study completedNCT06563856
What this trial is testing

TEPEZZA Subcutaneous Administration in Healthy Adults

Who this might be right for
BioavailabilityBioequivalence
Amgen 37
Large-scale testing (Phase 3)WithdrawnNCT02112643
What this trial is testing

Selenium in Mild Thyroid Eye Disease in North America

Who this might be right for
Thyroid Associated Ophthalmopathies
Columbia University
Testing effectiveness (Phase 2)Study completedNCT01868997
What this trial is testing

Teprotumumab (RV 001) Treatment in Patients With Active Thyroid Eye Disease

Who this might be right for
Thyroid Associated OphthalmopathiesThyroid-Associated Ophthalmopathy
Amgen 88
Large-scale testing (Phase 3)Active Not RecruitingNCT06812325
What this trial is testing

A Safety and Tolerability Study of VRDN-003 in Participants With Thyroid Eye Disease (TED)

Who this might be right for
Thyroid Eye Disease (TED)
Viridian Therapeutics, Inc. 321
Large-scale testing (Phase 3)Active Not RecruitingNCT05276063
What this trial is testing

A Phase 2b, Study of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED)

Who this might be right for
Thyroid Eye DiseaseGraves OrbitopathyEndocrine System Diseases+9 more
Sling Therapeutics, Inc. 90
Large-scale testing (Phase 3)UnknownNCT01809444
What this trial is testing

Prednisone Versus Doxycycline in the Treatment of Graves' Orbitopathy

Who this might be right for
Thyroid Associated Opthalmopathies
Sun Yat-sen University 146
Testing effectiveness (Phase 2)Study completedNCT05429450
What this trial is testing

Thyroid Associated Orbitopathy Treatment by Methotrexate Against Triamcinolone Periocular Injections

Who this might be right for
Thyroid Associated Orbitopathy
Cairo University 18
Large-scale testing (Phase 3)Study completedNCT03298867
What this trial is testing

Treatment of Graves' Orbitopathy (Thyroid Eye Disease) to Reduce Proptosis With Teprotumumab Infusions in a Randomized, Placebo-Controlled, Clinical Study

Who this might be right for
Thyroid Eye DiseaseGraves' Orbitopathy
Amgen 83
Large-scale testing (Phase 3)Study completedNCT06021054
What this trial is testing

An Efficacy, Safety, and Tolerability Study of Veligrotug (VRDN-001), in Participants With Chronic Thyroid Eye Disease (TED) (THRIVE-2)

Who this might be right for
Thyroid Eye Disease
Viridian Therapeutics, Inc. 188
Not applicableStudy completedNCT07341347
What this trial is testing

OCT Angiography Drived Alterations in Thyroid-associated Orbitopathy

Who this might be right for
Thyroid Associated Orbitopathy
Osijek University Hospital 68
Large-scale testing (Phase 3)Looking for participantsNCT03131726
What this trial is testing

Treatment of Graves´ophthalmopathy with Simvastatin (GO-S)

Who this might be right for
Graves OphthalmopathyThyroid Associated OphthalmopathyThyroid Associated Orbitopathy
Lund University 80
Early research (Phase 1)Study completedNCT06674941
What this trial is testing

A Trial to Investigate Teprotumumab (High-concentration Formulation) Subcutaneous Administration in Healthy Adult Non-Japanese and Japanese Participants

Who this might be right for
Healthy Volunteers
Amgen 44
Large-scale testing (Phase 3)Active Not RecruitingNCT06625398
What this trial is testing

An Efficacy, Safety, and Tolerability Study of VRDN-003 in Participants With Chronic Thyroid Eye Disease (TED)

Who this might be right for
Thyroid Eye Disease
Viridian Therapeutics, Inc. 195
Large-scale testing (Phase 3)Active Not RecruitingNCT06384547
What this trial is testing

A Randomized, Controlled, Safety and Tolerability Study of VRDN-001 in Participants With Thyroid Eye Disease (TED)

Who this might be right for
Thyroid Eye Disease
Viridian Therapeutics, Inc. 231
Large-scale testing (Phase 3)Study completedNCT05176639
What this trial is testing

A Safety, Tolerability and Efficacy Study of Veligrotug (VRDN 001) in Healthy Volunteers and Participants With Thyroid Eye Disease (TED) ( THRIVE )

Who this might be right for
Thyroid Eye Disease
Viridian Therapeutics, Inc. 113
Load More Results